U. S. Gov’t Awards Retractable Technologies Third Safety Syringe Contract under Bush Global HIV/AIDS Initiative LITTLE ELM, Texas–February 16, 2007–Retractable Technologies, Inc. (AMEX: RVP) announced today that it has been awarded its third major U.S. government contract to provide VanishPoint® safety syringes under the Bush Administration’s Global HIV/AIDS initiative (President’s

Retractable Technologies, Inc. Reports 30.1 Percent Increase in Sales in the First Quarter LITTLE ELM, Texas–May 17, 2006–Retractable Technologies, Inc. (AMEX:RVP), a leading maker of safety needle devices, today reported $5.5 million in total sales for the three months ended March 31, 2006, a 30.1 percent increase over the same

Retractable Technologies, Inc. Posts Record 4th Quarter, Full-Year 2005 Sales And $316,000 4th Quarter Net Income LITTLE ELM, TX, April 3, 2006 – Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported net income of $316,000 for the three months ending December 31, 2005 on

Retractable Technologies, Inc. Posts $27,621 In 3rd Quarter Net Income On Higher U. S. Unit Sales, Improved Profit Margins LITTLE ELM, TX, November 16, 2005—Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported net income of $27,621 for the three months ended September 30, 2005,

U. S. GOV’T AWARDS RETRACTABLE TECHNOLOGIES SECOND SAFETY SYRINGE CONTRACT UNDER BUSH GLOBAL HIV/AIDS INITIATIVE LITTLE ELM, TEXAS, Nov. 2, 2005-Retractable Technologies, Inc. (AMEX: RVP) announced today that it has been awarded its second major U.S. government contract to provide VanishPoint® safety syringes under the Bush Administration’s Global HIV/AIDS initiative 

RETRACTABLE TECHNOLOGIES, INC. RECEIVES F.D.A. APPROVAL FOR VANISHPOINT® SAFETY IV CATHETER LITTLE ELM, TEXAS, October 11, 2005—Retractable Technologies, Inc. (AMEX:  RVP), a leading maker of safety needle devices, announced today it has received U.S. Food and Drug Administration (FDA) 510k approval to market its new VanishPoint® automated retraction intravenous (IV)

RETRACTABLE TECHNOLOGIES, INC. SIGNS LICENSING AGREEMENT FOR DISTRIBUTION OF ITS SAFETY NEEDLE DEVICES IN CHINA LITTLE ELM, TEXAS, Aug. 9, 2005- In a landmark contract aimed at eliminating the spread of HIV/AIDS and other bloodborne diseases via contaminated needles in China, Retractable Technologies, Inc. (AMEX: RVP) announced today that it

RETRACTABLE TECHNOLOGIES, INC. REPORTS RECORD SALES FOR 2004 LITTLE ELM, TX, April 13, 2005—Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported record net revenues of $21.5 million for 2004, including reimbursed discounts of $0.4 million, an increase of 12.8% over 2003. Unit sales increased

Retractable Technologies, Inc. Reports Record Third Quarter Sales LITTLE ELM, TX, Nov 16, 2004—Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported record net revenues of $7.2 million for the three months ended September 30, 2004, an increase of 73.2% over the same period last

Retractable Technologies, Inc. Corrects Errors in October 11 Investrend Report and Press Release LITTLE ELM, TX, Oct. 22, 2004—Noting that it had discontinued Investrend’s fee-based research service on August 13, 2004, Retractable Technologies, Inc. (RVP: AMEX) announced today that an Investrend report and press release issued October 11 stated incorrectly